Evidence map›Paper›PMID 39705591›Full record

ArticleMolecular biology of the cell2025

Resolving the two-body problem: A postulated role for the V0 sector of the V0V1-ATPase in exosome biogenesis and multivesicular body fate.

Crislyn D'Souza-Schorey, Philip D Stahl

Abstract read
In one paragraph

Article in Molecular biology of the cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Crislyn D'Souza-SchoreyDepartment of Biological Sciences, University of Notre Dame, Notre Dame, IN.
Philip D StahlDepartment of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO.

Funding

New insights into extracellular signal transductionR01GM148708 · NIGMS · UNIVERSITY OF NOTRE DAME · PI CRISLYN D'SOUZA-SCHOREY · 2023 to 2026
$1.3M
New approaches to study tumor microvesiclesR03CA273469 · NCI · UNIVERSITY OF NOTRE DAME · PI D'SOUZA-SCHOREY, CRISLYN · 2022 to 2023
$157k
Pro-tumorigenic roles of a VHL isoform in Clear Cell Renal Cell CarcinomaR03CA273598 · NCI · UNIVERSITY OF NOTRE DAME · PI D'SOUZA-SCHOREY, CRISLYN · 2023 to 2024
$157k
NCI NIH HHS R03 CA273469NCI NIH HHS R03 CA273598NIGMS NIH HHS R01 GM148708
6 · The paper itself

Abstract

Because the discovery of the multivesicular body (MVB) as the origin of secreted vesicles or exosomes, the question arose and still looms-what distinguishes an MVB destined for fusion with the plasma membrane (EXO-MVB) facilitating exosome release from an MVB involved in transport of content to the lysosome (LYSO-MVB). Do they have independent origins? Hence, the two-body problem. We hypothesize that a key to this conundrum is the membrane spanning V0 sector of the proton pump, V0V1-ATPase. The V0V1-ATPase participates in the acidification of intracellular compartments, although V0 can function separately from V1 and different V0 isoforms are endowed with membrane binding capabilities that allow the V0V1-ATPase to selectively localize to different endocytic compartments including early and late endosomes and lysosomes. We propose that V0, in collaboration with cholesterol and phosphoinositides, plays a central role in the early endosome as a nucleation center to direct the de novo assembly of an EXO-MVB scaffold. The EXO-MVB scaffold may play multiple roles-operating as an assembly platform, participating in membrane fission as well as providing downstream navigational queues necessary for exosome secretion. Thus, V0 may represent an influential nexus, a starting point, in exosome biogenesis.

Indexed as

ExosomesLysosomesMultivesicular BodiesVacuolar Proton-Translocating ATPasesAnimalsBiological TransportCell MembraneEndosomesHumansVacuolar Proton-Translocating ATPases

Identifiers

PMID39705591
PMCPMC11742106

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.